$AWRE
AWARE INC /MA/

2021 Q3 Form 10-Q Financial Statement

#000156459021052320 Filed on October 27, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3 2020 Q2
Revenue $4.175M $2.474M $1.890M
YoY Change 68.76% -17.81% -37.21%
Cost Of Revenue $243.0K $149.0K $160.0K
YoY Change 63.09% -44.81% -50.0%
Gross Profit $3.932M $2.325M $1.730M
YoY Change 69.12% -15.15% -35.69%
Gross Profit Margin 94.18% 93.98% 91.53%
Selling, General & Admin $3.205M $2.513M $3.010M
YoY Change 27.54% 35.84% 69.1%
% of Gross Profit 81.51% 108.09% 173.99%
Research & Development $2.307M $2.332M $2.420M
YoY Change -1.07% 12.66% 15.79%
% of Gross Profit 58.67% 100.3% 139.88%
Depreciation & Amortization $171.0K $140.0K $130.0K
YoY Change 22.14% 27.27% 18.18%
% of Gross Profit 4.35% 6.02% 7.51%
Operating Expenses $5.512M $4.845M $5.430M
YoY Change 13.77% 23.91% 39.95%
Operating Profit -$1.580M -$2.520M -$3.700M
YoY Change -37.3% 115.38% 210.92%
Interest Expense $1.000K $10.00K $20.00K
YoY Change -90.0% -96.0% -92.86%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.579M -$2.513M -$3.680M
YoY Change -37.17% 173.15% 304.4%
Income Tax $0.00 -$700.0K -$500.0K
% Of Pretax Income
Net Earnings -$1.579M -$1.777M -$3.142M
YoY Change -11.14% 1084.67% 234.26%
Net Earnings / Revenue -37.82% -71.83% -166.24%
Basic Earnings Per Share -$0.07 -$0.08 -$0.15
Diluted Earnings Per Share -$0.07 -$0.08 -$0.15
COMMON SHARES
Basic Shares Outstanding 21.53M 21.48M 21.47M
Diluted Shares Outstanding 21.53M 21.48M 21.47M

Balance Sheet

Concept 2021 Q3 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $33.30M $42.30M $45.00M
YoY Change -21.28% -11.88% -8.16%
Cash & Equivalents $33.30M $42.32M $45.00M
Short-Term Investments
Other Short-Term Assets $745.0K $600.0K $300.0K
YoY Change 24.17% 50.0% 50.0%
Inventory
Prepaid Expenses
Receivables $6.407M $4.300M $4.400M
Other Receivables $1.398M $0.00 $0.00
Total Short-Term Assets $41.85M $47.20M $49.60M
YoY Change -11.34% -15.86% -11.11%
LONG-TERM ASSETS
Property, Plant & Equipment $3.333M $3.800M $3.800M
YoY Change -12.29% 0.0% -2.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $6.070M $5.000M $4.600M
YoY Change 21.4% -48.98% -50.54%
TOTAL ASSETS
Total Short-Term Assets $41.85M $47.20M $49.60M
Total Long-Term Assets $6.070M $5.000M $4.600M
Total Assets $47.92M $52.20M $54.20M
YoY Change -8.2% -20.79% -16.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $565.0K $300.0K $300.0K
YoY Change 88.33% 50.0% 50.0%
Accrued Expenses $2.057M $1.700M $1.900M
YoY Change 21.0% 30.77% 35.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.662M $5.000M $5.000M
YoY Change 13.24% -1.96% 28.21%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $106.0K $0.00 $100.0K
YoY Change -100.0% 0.0%
Total Long-Term Liabilities $106.0K $0.00 $100.0K
YoY Change -100.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.662M $5.000M $5.000M
Total Long-Term Liabilities $106.0K $0.00 $100.0K
Total Liabilities $5.768M $5.000M $5.100M
YoY Change 15.36% -1.96% 30.77%
SHAREHOLDERS EQUITY
Retained Earnings -$55.22M
YoY Change
Common Stock $97.37M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $42.15M $47.25M $49.05M
YoY Change
Total Liabilities & Shareholders Equity $47.92M $52.20M $54.20M
YoY Change -8.2% -20.79% -16.74%

Cashflow Statement

Concept 2021 Q3 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$1.579M -$1.777M -$3.142M
YoY Change -11.14% 1084.67% 234.26%
Depreciation, Depletion And Amortization $171.0K $140.0K $130.0K
YoY Change 22.14% 27.27% 18.18%
Cash From Operating Activities -$1.896M -$2.250M -$1.390M
YoY Change -15.73% 301.79% 9.45%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$110.0K -$60.00K
YoY Change -100.0% 1000.0% 20.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$110.0K -$60.00K
YoY Change -100.0% 1000.0% 20.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.000K -270.0K -450.0K
YoY Change -100.37% -28.95% 221.43%
NET CHANGE
Cash From Operating Activities -1.896M -2.250M -1.390M
Cash From Investing Activities 0.000 -110.0K -60.00K
Cash From Financing Activities 1.000K -270.0K -450.0K
Net Change In Cash -1.895M -2.630M -1.900M
YoY Change -27.95% 176.84% 30.14%
FREE CASH FLOW
Cash From Operating Activities -$1.896M -$2.250M -$1.390M
Capital Expenditures $0.00 -$110.0K -$60.00K
Free Cash Flow -$1.896M -$2.140M -$1.330M
YoY Change -11.4% 289.09% 9.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
awre Minimum Period Of Payment Of Transaction Price In Contract With Customer
MinimumPeriodOfPaymentOfTransactionPriceInContractWithCustomer
P30D
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
74000
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2474000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21549483
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21549483
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21378833
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21378833
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
215000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
214000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
96104000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-55217000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-50648000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
42149000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
45670000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47917000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1631000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4785000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3771000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1207000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51628000
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4175000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7883000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
243000
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
149000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
933000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
483000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2307000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2332000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7067000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7027000
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1306000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1574000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4644000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4170000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
5755000
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
4994000
us-gaap Costs And Expenses
CostsAndExpenses
17429000
us-gaap Costs And Expenses
CostsAndExpenses
15451000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1580000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2520000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4572000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7568000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
7000
us-gaap Investment Income Interest
InvestmentIncomeInterest
3000
us-gaap Investment Income Interest
InvestmentIncomeInterest
174000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1579000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2513000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4569000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7394000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-736000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1416000
us-gaap Net Income Loss
NetIncomeLoss
-5978000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21452000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21452000
us-gaap Net Income Loss
NetIncomeLoss
-5978000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
401000
us-gaap Share Based Compensation
ShareBasedCompensation
557000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
1179000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
71000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
525000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-786000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5218000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
54000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5268000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33297000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1777000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
97151000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12857000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
599000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
204000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4190000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
464000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-464000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
23000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
89000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
704000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-770000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5424000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42318000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
53435000
CY2020Q1 awre Shares Surrendered To Pay Taxes Related To Unrestricted Stock Value
SharesSurrenderedToPayTaxesRelatedToUnrestrictedStockValue
50000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
83000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-1060000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
52408000
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
23000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
230000
CY2020Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
469000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-3142000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
49050000
CY2020Q3 awre Shares Surrendered To Pay Taxes Related To Unrestricted Stock Value
SharesSurrenderedToPayTaxesRelatedToUnrestrictedStockValue
39000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
244000
CY2020Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
233000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
47245000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
45670000
CY2021Q1 awre Shares Surrendered To Pay Taxes Related To Unrestricted Stock Value
SharesSurrenderedToPayTaxesRelatedToUnrestrictedStockValue
54000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
197000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1448000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
44365000
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
25000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
439000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1542000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
43287000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
441000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1579000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
42149000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1077000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
557000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:20pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:10pt;text-align:justify;margin-bottom:0pt;margin-left:5.39%;text-indent:0%;;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">The preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period.  <span style="color:#000000;">The most significant estimates included in the financial statements pertain to revenue recognition, reserves for doubtful accounts, valuation of intangible assets and goodwill recorded as part of the combinations and valuation allowance for deferred income tax assets.</span> Actual results could differ from those estimates.</p>
awre Maximum Period Of Payment Of Transaction Price In Contract With Customer
MaximumPeriodOfPaymentOfTransactionPriceInContractWithCustomer
P60D
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4175000
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2474000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12857000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7883000
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2020Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2018000
CY2020Q3 awre Unbilled Receivables Current Revenue Recognized In Advance Of Billings
UnbilledReceivablesCurrentRevenueRecognizedInAdvanceOfBillings
492000
CY2020Q3 awre Unbilled Receivables Current Billings
UnbilledReceivablesCurrentBillings
283000
CY2020Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2227000
CY2021Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2867000
CY2021Q3 awre Unbilled Receivables Current Revenue Recognized In Advance Of Billings
UnbilledReceivablesCurrentRevenueRecognizedInAdvanceOfBillings
1660000
CY2021Q3 awre Unbilled Receivables Current Billings
UnbilledReceivablesCurrentBillings
1255000
CY2021Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3272000
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2961000
CY2020Q3 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
1400000
CY2020Q3 awre Contract With Customer Liability Revenue Recognized Additions Made During Period
ContractWithCustomerLiabilityRevenueRecognizedAdditionsMadeDuringPeriod
-1320000
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3041000
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2947000
CY2021Q3 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
1725000
CY2021Q3 awre Contract With Customer Liability Revenue Recognized Additions Made During Period
ContractWithCustomerLiabilityRevenueRecognizedAdditionsMadeDuringPeriod
-1526000
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3146000
CY2019Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3315000
awre Unbilled Receivables Current Revenue Recognized In Advance Of Billings
UnbilledReceivablesCurrentRevenueRecognizedInAdvanceOfBillings
752000
awre Unbilled Receivables Current Billings
UnbilledReceivablesCurrentBillings
1840000
CY2020Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2227000
CY2020Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2229000
awre Unbilled Receivables Current Revenue Recognized In Advance Of Billings
UnbilledReceivablesCurrentRevenueRecognizedInAdvanceOfBillings
3739000
awre Unbilled Receivables Current Billings
UnbilledReceivablesCurrentBillings
2696000
CY2021Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3272000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2837000
us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
4284000
awre Contract With Customer Liability Revenue Recognized Additions Made During Period
ContractWithCustomerLiabilityRevenueRecognizedAdditionsMadeDuringPeriod
-4080000
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3041000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3933000
us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
4043000
awre Contract With Customer Liability Revenue Recognized Additions Made During Period
ContractWithCustomerLiabilityRevenueRecognizedAdditionsMadeDuringPeriod
-4830000
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3146000
awre Percentage Of Remaining Performance Obligations Expected To Be Recognized As Revenue
PercentageOfRemainingPerformanceObligationsExpectedToBeRecognizedAsRevenue
0.67
awre Minimum Period Of Remaining Performance Obligations
MinimumPeriodOfRemainingPerformanceObligations
P12M
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2200000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33300000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38600000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
441000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
244000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
44000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
176000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
176000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
176000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
169000
CY2020Q4 awre Finite Lived Intangible Assets Amortization Expense Rolling After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFour
345000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1086000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1579000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1777000
us-gaap Net Income Loss
NetIncomeLoss
-4569000
us-gaap Net Income Loss
NetIncomeLoss
-5978000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21532000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21476000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21508000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21452000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21532000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21476000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21508000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21452000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-700000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1400000
CY2021Q3 awre Estimated Benefit Amount Federal Tax Refund Receivable
EstimatedBenefitAmountFederalTaxRefundReceivable
1500000

Files In Submission

Name View Source Status
0001564590-21-052320-index-headers.html Edgar Link pending
0001564590-21-052320-index.html Edgar Link pending
0001564590-21-052320.txt Edgar Link pending
0001564590-21-052320-xbrl.zip Edgar Link pending
awre-10q_20210930.htm Edgar Link pending
awre-10q_20210930_htm.xml Edgar Link completed
awre-20210930.xsd Edgar Link pending
awre-20210930_cal.xml Edgar Link unprocessable
awre-20210930_def.xml Edgar Link unprocessable
awre-20210930_lab.xml Edgar Link unprocessable
awre-20210930_pre.xml Edgar Link unprocessable
awre-ex311_8.htm Edgar Link pending
awre-ex312_6.htm Edgar Link pending
awre-ex321_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending